L'Oréal Reports FY25 Earnings Growth On Higher Revenue

L'Oreal reported FY2025 revenue of EUR 44.05 billion (up from EUR 43.49 billion) and operating earnings of EUR 8.89 billion (versus EUR 8.69 billion), while reported net income fell to EUR 6.13 billion from EUR 6.41 billion. Adjusted net income after non-controlling interests was EUR 6.81 billion (slightly above EUR 6.79 billion prior) and EPS rose to EUR 12.71 from EUR 12.66, despite currency headwinds and non‑recurring items; the stock traded down ~8.0% at $85.97 on the OTC market, signaling investor concern despite modest underlying earnings improvement.

Analysis

Market structure: L'Oreal's results show low-single-digit top-line growth (EUR44.05bn, +1.3% yoy) with modest margin expansion (op earnings +2.3%) and EPS essentially flat (+0.4%), implying demand is stable but currency and one-offs are driving headline noise. The 8% OTC selloff is a sentiment/flow event rather than a fundamentals shock — a technical-driven dislocation that benefits long-term holders and active buyers of high-quality consumer staples while hurting leveraged short-term momentum players.

Competitive dynamics & supply/demand: Persistent margin improvement signals pricing power and mix resilience versus peers (luxury cosmetics vs mass-market). If L'Oreal sustains ~2-3% operating leverage on low-single-digit revenue growth, it can steal share from weaker brands unable to raise prices without volume loss; raw-material and logistics risk remains the main supply-side constraint.

Cross-asset & risk lenses: Expect near-term EUR/USD sensitivity — another 3-5% move in EUR would swing reported EBIT by several hundred million euros; corporate bonds of consumer staples could tighten modestly on evidence of earnings stability. Tail risks (China regulatory re-tightening, commodity shock, large FX move) are low-probability but would compress multiples rapidly; a 6-12 month horizon should focus on FX and China macro as primary catalysts.

Implications for trading: The market reaction appears overdone given adjusted net income up slightly; this creates a mean-reversion opportunity. Key catalysts to watch in 30–90 days: Q1 sales trends in China/US, currency guidance, and management commentary on margins — any positive surprises should trigger a rapid re-rating within 3 months.

Key Decisions for Investors

• Establish a 2–3% position in L'Oreal via OR.PA (Euronext) or LRLCY (OTC) within the next 1–2 weeks, targeting an average entry if price falls to ~10% below the current OTC quote (~$78) and trimming if it recovers above +15% from entry within 6–12 months; rationale: resilient margins, pricing power, and an 8% sentiment-driven selloff.
• Implement a relative-value pair: long OR.PA (2%) vs short EL (Estée Lauder, 1.5%) for 6–12 months to express European beauty resilience vs US prestige exposure; size to be dollar-neutral and close if the spread narrows by 50% or after two consecutive quarters of divergent sales/margin prints.
• Buy a 9–12 month call spread to express upside with capped risk: e.g., buy OR.PA (or OTC-equivalent) LEAP call ~12 months out 0–15% OTM and sell a 25–40% OTM call to reduce premium; allocate no more than 0.5–1% of portfolio capital to this option position and re-evaluate after Q1 results and currency updates.
• Hedge EUR/USD FX risk for non-euro portfolios by buying EUR puts or entering a modest FX collar sized to the L'Oreal exposure if holdings exceed 3% of portfolio; exit or roll after 90 days if EUR moves <3% or after management updates FX net exposure.